{"id":"fecal-microbiota-transplantation","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Abdominal pain or cramping"},{"rate":"5-20","effect":"Diarrhea"},{"rate":"5-15","effect":"Nausea"},{"rate":"5-10","effect":"Fever"},{"rate":"5-10","effect":"Constipation"}]},"_chembl":{"chemblId":"CHEMBL6068500","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"FMT works by reintroducing diverse commensal bacteria and other microorganisms that establish a balanced microbiome, which can restore normal intestinal barrier function, competitive exclusion of pathogenic organisms, and immune homeostasis. This approach is particularly effective for recurrent or refractory Clostridioides difficile infection, where pathogenic overgrowth has disrupted the normal microbiota. The transplanted microbial community produces short-chain fatty acids, maintains pH balance, and reinforces intestinal epithelial integrity.","oneSentence":"Fecal microbiota transplantation (FMT) restores a healthy gut bacterial community by transferring stool from a healthy donor to a patient's colon.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:30:19.989Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Recurrent or refractory Clostridioides difficile infection"},{"name":"Ulcerative colitis (investigational)"},{"name":"Irritable bowel syndrome (investigational)"}]},"trialDetails":[{"nctId":"NCT06623461","phase":"PHASE2","title":"LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2025-04-07","conditions":"Melanoma","enrollment":128},{"nctId":"NCT06478602","phase":"PHASE3","title":"Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis","status":"COMPLETED","sponsor":"Cristian Ichim","startDate":"2024-08-05","conditions":"Liver Cirrhosis","enrollment":19},{"nctId":"NCT07496502","phase":"PHASE1, PHASE2","title":"Effect of Oral Microbiota on MDRO Decolonization","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2022-03-31","conditions":"Clostridioides Difficile Infection, Drug Resistance, Bacterial, Gastrointestinal Microbiome","enrollment":42},{"nctId":"NCT06591013","phase":"NA","title":"Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Nationality in the Treatment of IBD","status":"COMPLETED","sponsor":"First Affiliated Hospital of Kunming Medical University","startDate":"2022-10-14","conditions":"Inflammatory Bowel Diseases","enrollment":80},{"nctId":"NCT04090346","phase":"PHASE4","title":"Fecal Microbiota Transplant","status":"COMPLETED","sponsor":"Methodist Health System","startDate":"2018-06-05","conditions":"Clostridium Difficile Infection","enrollment":24},{"nctId":"NCT07490054","phase":"PHASE1","title":"Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Melana Yuzefpolskaya, MD","startDate":"2025-09-01","conditions":"Chronic Heart Failure","enrollment":40},{"nctId":"NCT05669846","phase":"PHASE2","title":"Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC","status":"RECRUITING","sponsor":"Diwakar Davar","startDate":"2025-01-08","conditions":"Non Small Cell Lung Cancer","enrollment":26},{"nctId":"NCT06290258","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-03-06","conditions":"Autism Spectrum Disorder, Gastrointestinal Diseases, Healthy","enrollment":60},{"nctId":"NCT04038619","phase":"PHASE1","title":"Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-01","conditions":"Colitis, Diarrhea, Malignant Genitourinary System Neoplasm","enrollment":40},{"nctId":"NCT04975217","phase":"EARLY_PHASE1","title":"Fecal Microbial Transplants for the Treatment of Pancreatic Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-12-14","conditions":"Pancreatic Ductal Adenocarcinoma","enrollment":10},{"nctId":"NCT05998213","phase":"PHASE2","title":"Transfer of Feces in Ulcerative Colitis 2","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2020-06-12","conditions":"Ulcerative Colitis, Ulcerative Colitis Flare, Ulcerative Colitis Acute","enrollment":85},{"nctId":"NCT07486492","phase":"EARLY_PHASE1","title":"Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2026-03-31","conditions":"Colorectal Cancer Metastatic, Fecal Microbiota Transplantation","enrollment":10},{"nctId":"NCT05333471","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplantation for Chronic Granulomatous Disease-Associated Colitis","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-08-08","conditions":"Chronic Granulomatous Disease-associated Colitis","enrollment":20},{"nctId":"NCT05174273","phase":"PHASE2, PHASE3","title":"Neurocognitive Effects of FMT in MDD Patients With and Without IBS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valerie Taylor","startDate":"2022-04-06","conditions":"Major Depressive Disorder, Irritable Bowel Syndrome","enrollment":133},{"nctId":"NCT04759001","phase":"PHASE1, PHASE2","title":"FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-02-18","conditions":"Enterobacteriaceae Infections, Multi-antibiotic Resistance","enrollment":52},{"nctId":"NCT05739864","phase":"PHASE1, PHASE2","title":"Superdonor FMT in Patients With Ulcerative Colitis","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-02-13","conditions":"Active Ulcerative Colitis","enrollment":42},{"nctId":"NCT06071312","phase":"PHASE1, PHASE2","title":"FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-09-23","conditions":"Clostridium Difficile, Ulcerative Colitis","enrollment":64},{"nctId":"NCT05739825","phase":"","title":"Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-02-13","conditions":"Clostridioides Difficile Infection Recurrence","enrollment":20},{"nctId":"NCT07481422","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"University of Rijeka","startDate":"2026-03-15","conditions":"Irritable Bowel Syndrome (IBS)","enrollment":70},{"nctId":"NCT07477782","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05","conditions":"Primary Sclerosing Cholangitis (PSC), Inflammatory Bowel Disease (IBD)","enrollment":72},{"nctId":"NCT07464392","phase":"NA","title":"FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2026-03-01","conditions":"Acute Pancreatitis","enrollment":150},{"nctId":"NCT03819296","phase":"PHASE1","title":"Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-21","conditions":"Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8","enrollment":800},{"nctId":"NCT07463248","phase":"PHASE2","title":"PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy","status":"NOT_YET_RECRUITING","sponsor":"Wang Xin","startDate":"2026-03-05","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":64},{"nctId":"NCT05067595","phase":"PHASE1","title":"Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-01-24","conditions":"Intestinal Graft Versus Host Disease","enrollment":72},{"nctId":"NCT04373473","phase":"PHASE2","title":"Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-09-14","conditions":"Adults With Ulcerative Colitis","enrollment":58},{"nctId":"NCT03786900","phase":"","title":"Fecal Microbiota Transplantation (FMT): PRIM-DJ2727","status":"AVAILABLE","sponsor":"Herbert DuPont, MD","startDate":"","conditions":"Recurrent Clostridium Difficile Infection, Multidrug-resistant Klebsiella Pneumoniae Urinary Tract Infection","enrollment":""},{"nctId":"NCT07458984","phase":"PHASE3","title":"FMT Capsules for rCDI","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-02-25","conditions":"Clostridioides Difficile Infection Recurrence, FMT","enrollment":76},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT07042438","phase":"PHASE2","title":"Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-02-11","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma","enrollment":56},{"nctId":"NCT06333795","phase":"NA","title":"Faecal Microbiota Transplantation Against Chronic Diarrhea in Patients With Systemic Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Aarhus","startDate":"2024-04-01","conditions":"Diarrhea, Systemic Sclerosis","enrollment":20},{"nctId":"NCT05917379","phase":"PHASE1, PHASE2","title":"The Efficacy and Safty of FMT in Patients With CID","status":"COMPLETED","sponsor":"Peking University Sixth Hospital","startDate":"2023-10-08","conditions":"Insomnia Chronic, Fecal Microbiota Transplantation, Sleep Disorder","enrollment":80},{"nctId":"NCT05740319","phase":"NA","title":"Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2023-06-10","conditions":"Irritable Bowel Syndrome","enrollment":102},{"nctId":"NCT07432984","phase":"PHASE2","title":"Fecal Microbiota Transplant(FMT) Combination With Tislelizumab in Advanced or Metastatic NSCLC","status":"NOT_YET_RECRUITING","sponsor":"Se-Hoon Lee","startDate":"2026-04-30","conditions":"Non Small Cell Lung Cancer","enrollment":15},{"nctId":"NCT06461208","phase":"PHASE3","title":"A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis","status":"RECRUITING","sponsor":"King's College London","startDate":"2023-06-21","conditions":"Liver Cirrhosis","enrollment":300},{"nctId":"NCT03562741","phase":"NA","title":"Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile","status":"RECRUITING","sponsor":"Krunal Patel","startDate":"2014-01-16","conditions":"Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection","enrollment":500},{"nctId":"NCT07421947","phase":"NA","title":"Effects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University of Zurich","startDate":"2026-04","conditions":"Coronary Artery Disease, Type 2 Diabetes Mellitus (T2DM)","enrollment":30},{"nctId":"NCT07375797","phase":"NA","title":"Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes","status":"RECRUITING","sponsor":"Central Jutland Regional Hospital","startDate":"2026-02-05","conditions":"Diabetes Mellitus Type 2, Fecal Microbiota Transplantation (FMT), Oral Glucose Tolerance Test","enrollment":16},{"nctId":"NCT06058520","phase":"EARLY_PHASE1","title":"Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2023-10-01","conditions":"Hidradenitis Suppurativa","enrollment":16},{"nctId":"NCT03524352","phase":"PHASE3","title":"the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nantes University Hospital","startDate":"2020-03-12","conditions":"Pouchitis","enrollment":42},{"nctId":"NCT06631586","phase":"PHASE2","title":"Standardized Microbiota Transplant Therapy in Crohn's Disease","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2025-01-15","conditions":"Crohn Disease","enrollment":120},{"nctId":"NCT03843385","phase":"PHASE3","title":"Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis","status":"RECRUITING","sponsor":"Andreas Stallmach","startDate":"2023-01-31","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases","enrollment":129},{"nctId":"NCT07401680","phase":"PHASE1","title":"Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population","status":"NOT_YET_RECRUITING","sponsor":"University of Alberta","startDate":"2026-03-01","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases, Clostridioides Difficile Infection","enrollment":85},{"nctId":"NCT05664113","phase":"PHASE1","title":"Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2025-07-07","conditions":"Gastro-Intestinal Disorder","enrollment":10},{"nctId":"NCT03686202","phase":"PHASE2, PHASE3","title":"Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2018-11-30","conditions":"All Solid Tumors","enrollment":65},{"nctId":"NCT06603883","phase":"PHASE2, PHASE3","title":"Efficacy of Fecal Microbiota Transplantation in ICU Patients With Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-10-19","conditions":"Gastrointestinal Dysfunction-induced Enteral Nutrition Intolerance","enrollment":60},{"nctId":"NCT07381374","phase":"NA","title":"Fecal Microbiota Transplantation in Children With ASD","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Children's Hospital","startDate":"2026-02-01","conditions":"Autism Spectrum Disorder","enrollment":75},{"nctId":"NCT07386795","phase":"NA","title":"The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-02-01","conditions":"Constipation - Functional, Chronic Constipation, Fecal Microbiota Transplantation","enrollment":19},{"nctId":"NCT07387952","phase":"NA","title":"The Safety and Efficacy of Fecal Microbiota Transplantation Combined With Nutritional Intervention in the Treatment of Functional Constipation：a Pilot Study","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-07-30","conditions":"Constipation - Functional, Fecal Microbiota Transplantation (FMT), Chronic Constipation","enrollment":5},{"nctId":"NCT03594487","phase":"PHASE1","title":"Fecal Microbiota Transplantation (FMT) of FMP30 in Relapsing-Remitting Multiple Sclerosis","status":"TERMINATED","sponsor":"Jeffrey Gelfand","startDate":"2018-11-16","conditions":"Relapsing Remitting Multiple Sclerosis","enrollment":5},{"nctId":"NCT05327790","phase":"PHASE2","title":"LFMT vs Placebo in New Biologic Start for Ulcerative Colitis","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2022-06-03","conditions":"Ulcerative Colitis","enrollment":40},{"nctId":"NCT07017946","phase":"PHASE1, PHASE2","title":"Intestinal Microbiome Transplant in ALS","status":"RECRUITING","sponsor":"Duke University","startDate":"2026-01-27","conditions":"Amyotrophic Lateral Sclerosis ALS","enrollment":20},{"nctId":"NCT07374094","phase":"","title":"Clostridioides Difficile: Understanding Responses and Treatment Effects","status":"RECRUITING","sponsor":"Umeå University","startDate":"2026-01-26","conditions":"Clostridioides Difficile Infection","enrollment":200},{"nctId":"NCT07371013","phase":"NA","title":"Fecal Microbiota Transplantation in Children With Autism Spectrum Disorder and Gastrointestinal Symptoms","status":"NOT_YET_RECRUITING","sponsor":"Institute of Mother and Child, Warsaw, Poland","startDate":"2026-01","conditions":"Autism Spectrum Disorder, Gastrointestinal Symptoms","enrollment":20},{"nctId":"NCT07364617","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD","status":"NOT_YET_RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2026-02-01","conditions":"Graft vs Host Disease","enrollment":35},{"nctId":"NCT07143981","phase":"","title":"The Fecal Microbiome Transplant (FMT) Study for Anorexia Nervosa","status":"RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2026-01-15","conditions":"Anorexia Nervosa","enrollment":20},{"nctId":"NCT03325855","phase":"","title":"Fecal Microbiota Transplant National Registry","status":"RECRUITING","sponsor":"American Gastroenterological Association","startDate":"2017-09-20","conditions":"Fecal Microbiota Transplantation, Clostridium Difficile Infection, Gut Microbiome","enrollment":4000},{"nctId":"NCT06649981","phase":"PHASE1","title":"Aging Resilience Through Microbiota Optimization and Regulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gonzalo Jorquera, PhD","startDate":"2025-01-10","conditions":"Resilience, Cognitive Function and Well-Being, Muscle Function, Handgrip Strength Test","enrollment":80},{"nctId":"NCT07348471","phase":"NA","title":"Fecal Microbiota Transplantation for the Treatment of ICU Delirium","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-02-01","conditions":"Delirium","enrollment":60},{"nctId":"NCT07342205","phase":"PHASE2, PHASE3","title":"A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation","status":"RECRUITING","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2025-12-10","conditions":"Acute Respiratory Distress Syndrome (ARDS), Acute Lung Injury(ALI), Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome","enrollment":60},{"nctId":"NCT07345403","phase":"","title":"GENECARD - the Use of Genetic, Epigenetic, Metabolomic, Proteomic and Microbiotic Markers, Image and Voice Biomarker Analyses, and Pre- and Intraoperative Clinical Data - to Predict Early Complications After Cardiac Surgery.","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2026-01-01","conditions":"Postoperative Delirium (POD), Postoperative Bleeding, Acute Kidney Injury","enrollment":3000},{"nctId":"NCT03483246","phase":"PHASE3","title":"Impact of Fecal Microbiota Transplantation in Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-09-17","conditions":"Ulcerative Colitis","enrollment":150},{"nctId":"NCT07332260","phase":"PHASE1","title":"Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University Hospital of North Norway","startDate":"2026-01","conditions":"Alzheimer s Disease, Faecal Microbiota Transplantation (FMT)","enrollment":10},{"nctId":"NCT06026371","phase":"PHASE2","title":"Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2023-12-12","conditions":"Acute Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm","enrollment":138},{"nctId":"NCT07331688","phase":"PHASE1, PHASE2","title":"CMTS0515-auWMT for Radiation Enteritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2025-12-08","conditions":"Radiation Enteritis","enrollment":60},{"nctId":"NCT04444362","phase":"NA","title":"Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV)","status":"ENROLLING_BY_INVITATION","sponsor":"Nanjing Medical University","startDate":"2025-01-01","conditions":"Cardiovascular Disease, Cardiopulmonary Bypass","enrollment":500},{"nctId":"NCT07319364","phase":"PHASE1","title":"A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Fecal Microbiota Transplantation (FMT), Gastrointestinal Neoplasms, Antineoplastic Agents","enrollment":90},{"nctId":"NCT06801665","phase":"PHASE2","title":"FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colon Cancer With Liver Metastasis","status":"RECRUITING","sponsor":"Hua Jiang","startDate":"2025-04-17","conditions":"Colon Cancer Liver Metastases","enrollment":30},{"nctId":"NCT05598112","phase":"EARLY_PHASE1","title":"Effect of Gut Microbiome Intervention on Aging Via Oral FMT","status":"RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2023-04-24","conditions":"Aging, Frailty","enrollment":210},{"nctId":"NCT03420482","phase":"PHASE2","title":"Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2018-04-01","conditions":"Hepatic Encephalopathy","enrollment":30},{"nctId":"NCT07247786","phase":"PHASE2","title":"Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)","status":"NOT_YET_RECRUITING","sponsor":"Fundación GECP","startDate":"2026-03-15","conditions":"Non Small Cell Lung Cancer, Respiratory Tract Neoplasm","enrollment":68},{"nctId":"NCT07276464","phase":"","title":"Characterization of the Gut Microbiota Signature According to Physical Fitness and Its Implications for Intestinal Health.","status":"RECRUITING","sponsor":"University of Rennes 2","startDate":"2025-11-17","conditions":"Healthy","enrollment":30},{"nctId":"NCT04729322","phase":"PHASE2","title":"Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-02-22","conditions":"Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8","enrollment":15},{"nctId":"NCT07292142","phase":"PHASE1, PHASE2","title":"FMT in Triple Negative Breast Cancer Guided by ctDNA","status":"NOT_YET_RECRUITING","sponsor":"Jewish General Hospital","startDate":"2026-02","conditions":"Breast Cancer","enrollment":125},{"nctId":"NCT07106580","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization","status":"RECRUITING","sponsor":"University of Rijeka","startDate":"2025-07-28","conditions":"Colonization, Asymptomatic","enrollment":48},{"nctId":"NCT05831189","phase":"PHASE3","title":"A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2023-04-21","conditions":"Clostridium Difficile Infection Recurrence","enrollment":41},{"nctId":"NCT05248191","phase":"PHASE1","title":"FMT for Postop Crohn's Disease","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2022-04-20","conditions":"Crohn Disease","enrollment":23},{"nctId":"NCT06218602","phase":"PHASE2","title":"Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-02-19","conditions":"Lymphoma","enrollment":40},{"nctId":"NCT07276100","phase":"PHASE2","title":"Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab","status":"RECRUITING","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2026-01-01","conditions":"Hepato Cellular Carcinoma (HCC)","enrollment":15},{"nctId":"NCT03829475","phase":"PHASE2","title":"ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2020-01-01","conditions":"Inflammatory Bowel Diseases, Clostridium Difficile Infection","enrollment":61},{"nctId":"NCT07265817","phase":"NA","title":"Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms","status":"NOT_YET_RECRUITING","sponsor":"Kyungpook National University Hospital","startDate":"2025-12-01","conditions":"Carbapenem-Resistant Enterobacteriaceae Colonization","enrollment":60},{"nctId":"NCT04924270","phase":"PHASE2","title":"Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases","status":"RECRUITING","sponsor":"Odense University Hospital","startDate":"2023-12-13","conditions":"Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis","enrollment":200},{"nctId":"NCT05533983","phase":"NA","title":"FMT With Nivolumab in Patients With Advanced Solid Cancers Who Have Progressed During Anti-PD-(L)1 Therapy","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2023-03-08","conditions":"Solid Carcinoma","enrollment":50},{"nctId":"NCT07261826","phase":"","title":"Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics","status":"RECRUITING","sponsor":"Chen QiYi","startDate":"2025-09-01","conditions":"Clostridium Difficile Infection Recurrence, Ulcerative Colitis (UC), Crohn Disease (CD)","enrollment":4000},{"nctId":"NCT03819803","phase":"PHASE3","title":"Fecal Microbiota Transplantation in aGvHD After ASCT","status":"RECRUITING","sponsor":"Medical University of Graz","startDate":"2017-03-01","conditions":"Graft Versus Host Disease in GI Tract","enrollment":15},{"nctId":"NCT06692361","phase":"NA","title":"Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder","status":"RECRUITING","sponsor":"Gang Wang","startDate":"2025-01-01","conditions":"Major Depressive Disorder (MDD), Depression - Major Depressive Disorder","enrollment":214},{"nctId":"NCT02269150","phase":"PHASE2","title":"Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2014-10","conditions":"Allogeneic Hematopoietic Stem Cell","enrollment":59},{"nctId":"NCT06206707","phase":"NA","title":"FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2024-01-23","conditions":"Diarrhea, Colitis, Malignant Melanoma","enrollment":20},{"nctId":"NCT05911997","phase":"PHASE1","title":"MTC Versus FMT in for RCDI","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2024-01-08","conditions":"Clostridiodies Difficile Infections","enrollment":60},{"nctId":"NCT06321536","phase":"PHASE2","title":"Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-01-13","conditions":"Multi-Drug Resistant Organism Colonization","enrollment":60},{"nctId":"NCT07223606","phase":"","title":"Fecal Microbiota Transplant for Neuroblastoma in a Single Patient","status":"NO_LONGER_AVAILABLE","sponsor":"ProgenaBiome","startDate":"","conditions":"Neuroblastoma, Neuroblastoma (NB), Neuroblastoma (NBL)","enrollment":""},{"nctId":"NCT05776914","phase":"PHASE2","title":"Fecal Microbiota Transplantation for IBS","status":"RECRUITING","sponsor":"Madhusudan (Madhu) Grover, MBBS","startDate":"2024-04-15","conditions":"Irritable Bowel Syndrome, Diarrhea","enrollment":43},{"nctId":"NCT05632315","phase":"PHASE2","title":"PMT for MDRO Decolonization","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-08-19","conditions":"Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa","enrollment":150},{"nctId":"NCT06481852","phase":"PHASE1","title":"A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-10-28","conditions":"Pulmonary Arterial Hypertension","enrollment":24},{"nctId":"NCT06370884","phase":"PHASE1","title":"Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-02-01","conditions":"Recurrent Clostridioides Difficile Infection, Colonic Surgery","enrollment":40},{"nctId":"NCT04883762","phase":"PHASE1","title":"Stool Transplant to Control Treatment-related Diarrhea","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-05-10","conditions":"Fecal Microbiota Transplantation (FMT)","enrollment":4},{"nctId":"NCT07196189","phase":"","title":"Effects of Fecal Microbiota Transplantation","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2022-03-16","conditions":"Eating Disorders Symptoms","enrollment":84},{"nctId":"NCT06030037","phase":"PHASE2","title":"Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma","status":"WITHDRAWN","sponsor":"Diwakar Davar","startDate":"2025-03-11","conditions":"PD-1 Refractory Advanced Melanoma","enrollment":""},{"nctId":"NCT07194941","phase":"PHASE2","title":"Efficacy and Safety of Fecal Microbiota Transfer (FMT) for Recurrent Urinary Tract Infections in Women","status":"COMPLETED","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2022-08-25","conditions":"Recurrent Urinary Tract Infections in Women","enrollment":40},{"nctId":"NCT07190183","phase":"","title":"Washed Microbiota Transplantation for Food Intolerance","status":"RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2025-01-01","conditions":"Food Intolerance","enrollment":100},{"nctId":"NCT04630847","phase":"PHASE1","title":"Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders","status":"NOT_YET_RECRUITING","sponsor":"ProgenaBiome","startDate":"2025-12","conditions":"Autism, Autism Spectrum Disorder","enrollment":10}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"SEPSIS"},{"count":1,"reaction":"CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY"},{"count":1,"reaction":"DRUG INEFFECTIVE"},{"count":1,"reaction":"GASTROENTERITIS ESCHERICHIA COLI"},{"count":1,"reaction":"GUILLAIN-BARRE SYNDROME"},{"count":1,"reaction":"MALAISE"},{"count":1,"reaction":"PARALYSIS"},{"count":1,"reaction":"PROBIOTIC THERAPY"}],"_approvalHistory":[],"publicationCount":6200,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["FMT","Fecal Transplant","Microbiota transfer therapy (MTT)","(PRIM-DJ2727)","Fecal Microbiota Preparation Delivery Capsule"],"phase":"marketed","status":"active","brandName":"Fecal Microbiota Transplantation","genericName":"Fecal Microbiota Transplantation","companyName":"University of California, Los Angeles","companyId":"university-of-california-los-angeles","modality":"Biologic","firstApprovalDate":"","aiSummary":"Fecal microbiota transplantation (FMT) restores a healthy gut bacterial community by transferring stool from a healthy donor to a patient's colon. Used for Recurrent or refractory Clostridioides difficile infection, Ulcerative colitis (investigational), Irritable bowel syndrome (investigational).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":42,"withResults":8},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}